Psychedelic therapy training for mental health professionals

Learn to navigate non-ordinary states to better serve your clients

Beckley Academy prepares and trains providers to support patients to heal their mental health challenges with Ketamine, Psilocybin and MDMA.

FDA clinical trials for psychedelic-assisted therapy (PAT) with MDMA and Psilocybin have shown potential for treating PTSD, depression, anxiety and other mental health issues. Ketamine-Assisted Therapy is a legal treatment today. Approval for MDMA treatment and Psilocybin is expected in 2024 and 2026, respectively.

Ketamine

MDMA

Psilocybin

More about our first program:
Foundations of Psychedelic-Assisted Therapy (PAT)

Training overview:

100% Online | 13 weeks | Intimate cohort | Accessible pricing | Scholarships available

  • Foundations, origins, legacy, and contemporary uses of psychedelics 
  • Complexities of power, responsibility, and empowerment within the therapeutic alliance 
  • In-depth clinical psychedelic research (and understand the limitations of research)
  • Relational ethics and creating a safe container
  • Build a framework for self-reflection & self-regulation
  • Understand the influence of set and setting on the therapeutic alliance
  • How to navigate common and unexpected transference & countertransference in non-ordinary states
  • How to provide culturally-responsive care and practice from a decolonizing perspective
  • Practice a somatic and trauma-informed approach
  • Practice a non-directive clinical approach, based on noticing and following inner experience
  • Practice skills to support non-ordinary states of consciousness such as tracking somatic experience, co-regulation, embodying belief, and proximity seeking actions
  • Create a toolkit of resources to incorporate into your practice: somatic resources, intention setting, PAT music playlists, client psychoeducation, transformation, and integration techniques